Scientific Advisory Council
Our Scientific Advisory Council Members
|Sumit R. Majumdar, MD, MPH, FRCPC, FACP
Professor of Medicine
Member of the SAC since 2010
Areas of Interest/Expertise: Secondary Fracture Prevention; Knowledge Translation; Pharmaco- And Clinical-Epidemiology; Quality Improvement.
Dr. Majumdar is a Professor of Medicine, an Alberta Heritage Foundation / Alberta Innovates – Health Solutions Health Scholar, and the Endowed Chair in Patient Health Management, Faculties of Medicine and Dentistry and Pharmacy and Pharmaceutical Sciences at the University of Alberta. He is also an Adjunct Professor at the University of Alberta School of Public Health and a Visiting Professor at Harvard Medical School. Clinically, he works as a general internist and ward-attending physician at the University Hospital in Edmonton, Alberta.
He obtained his BSc (Honours Biology) in 1988 at the University of Calgary; his MD at the University of Alberta in 1992; and his MPH at the Harvard School of Public Health in 1999. He did his residency/chief residency/fellowship training at the University of Alberta (Internal Medicine, 1992-97) and did a health outcomes and pharmacoepidemiology fellowship at Harvard Medical School (1997-00).
Since starting on Faculty in 2000, he has obtained more than $30 million dollars in peer-reviewed funding (Principal or co-Principal Investigator for more than half these funds) and has published more than 200 peer-reviewed articles in journals such as Annals of Internal Medicine, Archives of Internal Medicine, BMJ, CMAJ, JAMA, and Lancet. He has an h-index of 40 and his work has been cited more than 5000 times. To date, he has supervised or co-supervised 30 research trainees. His work has been recognized at local (Department Translational Research Award), national (Young Investigator of the Year, Canadian Society of Internal Medicine), and international (Mack Lipkin Award, Society of General Internal Medicine) levels.
Dr. Majumdar’s research is directed at improving the quality of care for people with chronic conditions such as osteoporosis. To fulfill this knowledge translation research agenda, his work has followed three inter-related lines of inquiry:
(1) Why does underuse of proven effective treatments exist?
(2) What are the barriers to, and the facilitators of, best practice? and
(3) How can we improve practice and optimize use of evidence-based treatments?
Professional Awards and/or Accomplishments: